Cancer vaccines: the perspective of the Cancer Immunology Branch, NCI.
The Cancer Immunology Branch, NCI, is supporting a great deal of exciting research relevant to cancer vaccine development. The few areas highlighted here are representative of ongoing research opportunities, but further progress depends largely on a continued infusion of investigator-initiated ideas to realize the potential of current research areas and open new ones.
Sogn
J A
JA
Cancer Immunology Branch, National Cancer Institute, NIH, Bethesda, Maryland 20892.
Finerty
J F
JF
Heath
A K
AK
Shen
G L
GL
Austin
F C
FC
D000951:Antigens, Neoplasm / Q000276:immunology; D006801:Humans; D007108:Immune Tolerance; D007111:Immunity, Cellular; D016233:Immunotherapy, Active; D009316:National Institutes of Health (U.S.); D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D012109:Research Support as Topic; D014481:United States
D000951:Antigens, Neoplasm